The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin

被引:0
|
作者
Mbarki, S. [1 ]
Abdesselem, S. [1 ]
Kallel, A. [1 ]
Jemaa, R. [1 ]
Rekik, B. [1 ]
Jamaa, M. [1 ]
Kaabechi, N. [1 ]
Mechmeche, R. [1 ]
机构
[1] La Rabta Univ Hosp, Tunis, Tunisia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P2102
引用
收藏
页码:370 / 370
页数:1
相关论文
共 50 条
  • [1] The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate
    Christidis, Dimitrios S.
    Liberopoulos, Evangelos N.
    Kakafika, Anna I.
    Miltiadous, George A.
    Cariolou, Marios
    Ganotakis, Emmanuel S.
    Mikhailidis, Dimitri P.
    Elisaf, Moses S.
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2006, 11 (03) : 211 - 221
  • [2] The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with fenofibrate or atorvastatin
    Christidis, D.
    Liberopoulos, E.
    Kakafika, A.
    Cariolou, M.
    Elisaf, M.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 560 - 560
  • [3] Lipid-lowering effect of atorvastatin in heart transplantation
    Bonet, LA
    Martínez-Dolz, L
    Vives, MAA
    Soriano, JR
    Sáez, AO
    Gisbert, FD
    Pérez, MP
    [J]. TRANSPLANTATION PROCEEDINGS, 2002, 34 (01) : 179 - +
  • [4] Lipid-lowering efficacy of atorvastatin
    Adams, Stephen P.
    Tsang, Michael
    Wright, James M.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (03):
  • [5] The correlation between apolipoprotein E gene polymorphism and the lipid-lowering effects of two statins
    Zhang, Q.
    Wu, Y-D.
    [J]. JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2022, 36 (02): : 287 - 293
  • [6] The lipid-lowering effect of atorvastatin in Taiwanese diabetic patients with hyperlipidemia
    Chang, Chwen-Tzuei
    Lee, Jenn-Kuen
    Lin, Jen-Der
    Hung, Yi-Jen
    Liu, Rue-Tsuan
    Shau, Wen-Yi
    Sheu, Wayne Huey-Herng
    [J]. TZU CHI MEDICAL JOURNAL, 2013, 25 (03): : 168 - 174
  • [7] The Lipid-Lowering Effect of Atorvastatin in Acute Coronary Syndrome Patients
    Ying, Ku Ming
    Tan, S. S. N.
    Tan, C. S. Y.
    Tiong, L. L.
    Lim, A. M. W.
    Ling, D. E.
    Hii, E. H. H.
    Kiu, I. S. N.
    Wong, L. W.
    Ting, M. L. L.
    Sumbai, M. E.
    Chua, A. T. P.
    Douglas, J. S.
    Theng, M. L.
    Chew, S. W.
    Fong, A. Y. Y.
    Ong, T. K.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 273 : 7 - 8
  • [8] Genetic determinants of lipid-lowering response to atorvastatin therapy in an Indian population
    Kadam, P.
    Ashavaid, T. F.
    Ponde, C. K.
    Rajani, R. M.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2016, 41 (03) : 329 - 333
  • [9] Apolipoprotein E genotype as a most significant predictor of lipid response at lipid-lowering therapy: Mechanistic and clinical studies
    Dergunov, A. D.
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2011, 65 (08) : 597 - 603
  • [10] Apolipoprotein E epsilon-4 polymorphism is associated with younger age at referral to a lipidology clinic and a poorer response to lipid-lowering therapy
    Rui Baptista
    Marta Rebelo
    Joana Decq-Mota
    Patrícia Dias
    Pedro Monteiro
    Luís A Providência
    José M Silva
    [J]. Lipids in Health and Disease, 10